A new longitudinal study has shown that a nutritional drink designated a "food for special medical purposes" containing the multinutrient combination Fortasyn Connect can benefit patients with the earliest stages of Alzheimer's disease (AD), mild cognitive impairment, who are at risk of progressing to the dementia stage of AD, report scientists in the Journal of Alzheimer's Disease Reports.
Source: Medical Xpress
